Metabolic Medicine Summit 2026

Meet Our Featured Speakers

Sansei Fowler

CVS Health

Namrita Negi

Deloitte

Sansei Fowler

CVS Health

Steve Winshel

FULLFILL

THE FORUM FOR METABOLIC MEDICINE AND TREATMENT DEVELOPMENT

Welcome to the Metabolic Medicine Summit 2026, an event that brings together industry leaders and healthcare innovators committed to advancing metabolic therapies, technologies, and clinical strategies that are shaping the future of metabolic health.

Metabolic medicine faces significant challenges in turning advancements in gene editing, biomarkers, and precision therapies into meaningful clinical outcomes. This summit will highlight innovative approaches that aim to improve patient care and treatment.

Join us to gain practical insights, connect with global leaders, and help shape the future of metabolic health through innovation and collaboration.

key topics for

Emerging trends in metabolic therapies and patient-centered care

Innovative precision therapies targeting individual metabolic needs, along with patient-centered care models, are transforming treatment strategies worldwide.

Advancing biomarker-based research to enhance clinical outcomes

Biomarker research supports precise, effective treatments by identifying disease-specific markers that enhance outcomes and personalize care.

Case studies and clinical trials on therapies for metabolic disorders

Clinical trial data and case studies demonstrate the safety, effectiveness, and real-world impact of emerging therapies for metabolic disorders.

Breakthrough in therapeutic approaches for obesity and metabolic disorders

Advanced therapies for obesity and related metabolic dysfunctions using emerging drug platforms to improve health outcomes.

Innovations in biosimilars and peptide drugs for advanced treatments

Biosimilars and peptides provide cost-effective alternatives, as well as innovative therapies, for managing complex metabolic disorders.

Shaping metabolic medicine with global compliance and regulatory standards

New guidelines ensure the safety, effectiveness, and quality of metabolic therapies, aligning treatment practices with global standards to improve patient care and outcomes.

VIEW PROGRAM

INDUSTRY TOPICS

NETWORKING EVENTS

LEADING EXPERTS

Q&A SESSIONS

Latest News

RESEARCH
30 Jan 2026
New Metabolic Data Reignite Interest in Liver-Targeted Lipid Drugs
PARTNERSHIPS
20 Jan 2026
Roche’s 89bio Deal Heats Up the Race for MASH Drugs
INSIGHTS
19 Jan 2026
A $160M Biotech Bet Points to Obesity Drugs’ Next Test
RESEARCH
16 Jan 2026
FDA Fast Tracks Dual-Action MASH Drug: Is Momentum Back?